Merck Dodges Fosamax Claims in Latest Bellwether Trial; Defense Record Now 4-1

Merck Dodges Fosamax Claims in Latest Bellwether Trial; Defense Record Now 4-1


In its fifth time at bat in trials over injuries allegedly caused by the osteoporosis drug Fosamax, Merck on Monday knocked out the case of a woman who blamed her severe jaw and dental problems on the drug. It's the fourth trial win for Merck in bellwether trial.

www.flanziglaw.com
www.nyelderabuse.com

Categories